Production of antimicrobials
Download the brochure: Production of antimicrobials
Get the latest news and insights from the world of food safety and subscribe also to our newsletter.
Download the brochure: Production of antimicrobials
Get the latest news and insights from the world of food safety and subscribe also to our newsletter.
Why?
Much of the antimicrobials used today are derived from microbes and produced by fermentation. Regulation 1831/2003 sets out the rules for the authorization of feed additives, which includes the prohibition of authorisation of any antimicrobials as feed additives (growth promoters) in the EU.
Therefore, the production of antimicrobials must be tested for non-QPS strains used as such or for the production of feed additives.
Applicants should also declare if antimicrobials of clinical relevance are used during manufacturing of the product. In the case of food enzymes, the potential for antimicrobial production by the production organism is assessed based on the whole genome sequence.
How?
Since there is no internationally recognized standard available for the test, EFSA guidance is followed.
The inhibitory activity of culture supernatants is assessed against reference strains susceptible to a range of antimicrobials, or against other reference strains.
(e.g. Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, Staphylococcus aureus ATCC 25923, Enterococcus faecalis ATCC 29212, Bacillus subtilis ATCC 6633)
We recommend that the supernatants are sampled from authentic production conditions to better reflect the metabolism of the microorganism at the time of harvesting. The sample can be filtered to remove bacterial cells from the supernatant.
Agar well diffusion and agar disc diffusion methods (FAO, 2006) are commonly used for the assessment of antimicrobial activity; Biosafe Ltd. uses the agar disc diffusion method. Positive controls (antimicrobial) and negative controls (solvents, growth medium) are needed to verify the validity of the results.
If the test microorganism produces antimicrobial(s), the substance(s) should be identified. Furthermore, the absence of carry-over into the final product should be demonstrated using a sensitive method.
Contact us
Jouni Heikkinen
Key Account Manager, PhD
+358 40 016 5829
jouni.heikkinen@biosafe.fi
Arja Tervahauta
R&D Manager, PhD
+358 40 6196 222
arja.tervahauta@biosafe.fi
Pilvi Ruotsalainen
Microbiologist, PhD
+358 40 5050 607
pilvi.ruotsalainen@biosafe.fi
Book an appointment
for a consultation
Request a quote or ask for more information!
You can also make an appointment for a consultation.